Alpha Tau Medical
Most recent annual filing: 2025-12-31
- Head & Neck Cancer +2026Head & Neck Cancer +, 2026, routine
- Alpha DaRT SCC pivotal topline3Q 2026Alpha DaRT SCC pivotal topline, 3Q 2026, thesis-defining
- IMPACT pancreas pilot corporate updateLate 2026 / early 2027IMPACT pancreas pilot corporate update, Late 2026 / early 2027, routine
- Pancreas IMPACT corporate updateearly 2027Pancreas IMPACT corporate update, early 2027, routine
Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.
Pipeline (6 active programs)
Alpha DaRT
CTP-GBM-01Technology platforms
Alpha DaRT
Alpha Diffusing Alpha-emitters Radiation Therapy — intratumoral Radium-224-embedded radioactive source technology delivering controlled release of alpha-emitting atoms throughout solid tumors; focus areas include squamous cell carcinoma, glioblastoma multiforme, pancreatic cancer, head and neck cancer, and other solid tumors
Biotech Distilled coverage (17)
- 2026-08-31 UPDATE: Alpha Tau Medical (DRTS) — IMPACT Closes at 48 Patients, Four Times the Original Design 🔒 Paid
- 2026-08-11 UPDATE: Alpha Tau Medical (DRTS) — The Share Count Answer, And a $68.8M Loss That Isn’t 🔒 Paid
- 2026-07-21 UPDATE: Alpha Tau Medical (DRTS) — The Abscopal Bet Cashes a Ticket 🔒 Paid
- 2026-06-12 UPDATE: Alpha Tau Medical (DRTS) — FDA Greenlights REGAIN Expansion, Two New Sites Join
- 2026-06-03 UPDATE: Alpha Tau Medical (DRTS) — Tolmar Takes Prostate, And It Pays a Premium
- 2026-06-01 UPDATE: Alpha Tau Medical (DRTS) — The Pancreas OS Number Lands, And It’s Better Than the Benchmarks 🔒 Paid
- 2026-05-12 UPDATE: Alpha Tau Medical (DRTS) — The Unforgiving Organ Talks Back, And It Says Yes 🔒 Paid
- 2026-05-08 UPDATE: Alpha Tau Medical (DRTS) — ReSTART Enrollment Done, GBM Safety Call Set, Italy Opens 🔒 Paid
- 2026-05-04 UPDATE: Alpha Tau Medical (DRTS) — 100% Local Disease Control at the DDW Podium
- 2026-04-29 UPDATE: Alpha Tau Medical (DRTS) — The $300M Shelf Lands, ASCO Caps the Pancreas Run 🔒 Paid
- 2026-04-27 UPDATE: Alpha Tau Medical (DRTS) — The Pancreas Franchise Goes Global, IMPACT Slips a Quarter 🔒 Paid
- 2026-03-14 UPDATE: Alpha Tau (DRTS) - FY25 Financials 🔒 Paid
- 2026-02-28 UPDATE: Alpha Tau (DRTS) – The Japan Catalyst Hits 🔒 Paid
- 2026-01-30 UPDATE: Alpha Tau (DRTS) Doubles Down on the U.S. 🔒 Paid
- 2026-01-07 UPDATE: Alpha Tau Medical (DRTS) – Pancreatic Data Hits the "Safety" Bullseye; FDA Submission Adds Regulatory Momentum 🔒 Paid
- 2026-01-04 The Alpha Wars: Physics vs. Chemistry (DRTS vs. CATX) 🔒 Paid
- 2026-01-03 Alpha Tau Medical (DRTS): Scientific Deep Dive of Alpha DaRT 🔒 Paid
Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.